RxDoctor Payments Data

Eesha Bhattacharyya, MD

Obstetrics & Gynecology · Kailua, HINPI 1366476376

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $45,000 of the $66,025 with a category attached, or 68.2%. Applied Medical Resources Corporation accounts for 73.9% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $18,039 and has fallen 63.4% since, to $6,610 in 2025. Among obstetrics & gynecology clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$66,025in general payments, 2019–2025

Across 152 payments — averaging $434.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Applied Medical Resources Corporation$49K
  • Olympus Corporation Of The Americas$6K
  • Acessa Health Inc.$4K
  • Covidien LP$3K
  • Intuitive Surgical$2K
  • Hologic Sales And Service, LLC$537
  • plus $2K from 17 others

What the payments were for

  • Consulting fees$6,2009%
  • Speaking & faculty fees$45,00068%
  • Travel & lodging$5,2608%
  • Food & beverage$3,5525%
  • Education$6,0139%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,025 in reported general payments places this provider in the 95th percentile of 225 obstetrics & gynecology providers in Hawaii.

See all obstetrics & gynecology providers in Hawaii

Medicare billing

Part B allowed, 2024
$14,976
Medicare patients
49
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Evenity (2 Syringes)Romosozumab-Aqqg11$27,164
Raloxifene Hcl56$7,131
Tolterodine Tartrate ErTolterodine Tartrate12$1,407
Estradiol32$733
Medroxyprogesterone Acetate29$573

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEvenity (2 Syringes)$55$27,16411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 225 obstetrics & gynecology providers in Hawaii.

Other obstetrics & gynecology in Kailua

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →